Aptamer-based sustained release of therapeutic agents

Abstract

The present disclosure provides compositions comprising an aptamer and a molecular payload, wherein the aptamer is a sustained release carrier for the molecular payload. The molecular payload may be a therapeutic agent. The compositions thus provide a means of controlled and prolonged delivery of therapeutic agents. The present disclosure further provides kits comprising the compositions, methods of treating or preventing a disease or disorder, and methods of preparing the compositions.

Dependencies are inferred from the claim text.